WHO temporarily pauses hydroxychloroquine study, citing safety concerns


The World Health Organization is temporarily halting a study on hydroxychloroquine and chloroquine as potential COVID-19 treatments due to safety concerns.
WHO Director-General Tedros Adhanom Ghebreyesus announced the decision on Monday, after a study published in The Lancet medical journal suggested COVID-19 patients treated with hydroxychloroquine and chloroquine were more likely to die, CNN reports. The drugs were being reviewed as part of the WHO's Solidarity Trial — a coronavirus research effort involving more than 400 hospitals in 35 countries.
President Donald Trump last week revealed he takes hydroxychloroquine as a preventative measure against COVID-19, despite there being no evidence of its effectiveness and the FDA cautioning against the drug due to serious side effects including abnormal heart rhythms. Meanwhile Brazilian President Jair Bolsonaro is touting the other drug halted in the study, chloroquine.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The Data Safety Monitoring Board will review data about the drugs to assess whether they should continue to be used in the trial, though other arms of the trial will carry on, per CNN.
Tedros noted the halt concerns hydroxychloroquine and chloroquine as they pertain to COVID-19. "I wish to reiterate that these drugs are accepted as generally safe for use in patients with autoimmune diseases or malaria," he said.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Taylor Watson is audience engagement editor for TheWeek.com and a former editorial assistant. She graduated from Syracuse University, with a major in magazine journalism and minors in food studies and nutrition. Taylor has previously written for Runner's World, Vice, and more.
-
5 artfully drawn cartoons about Donald Trump's Epstein doodle
Cartoons Artists take on a mountainous legacy, creepy art, and more
-
Violent videos of Charlie Kirk’s death are renewing debate over online censorship
Talking Points Social media ‘promises unfiltered access, but without guarantees of truth and without protection from harm’
-
What led to Poland invoking NATO’s Article 4 and where could it lead?
TODAY'S BIG QUESTION After a Russian drone blitz, Warsaw’s rare move to invoke the important NATO statute has potentially moved Europe closer to continent-wide warfare
-
Texas declares end to measles outbreak
Speed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agency
Speed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC